While progress has been made to influence the treatment landscape of Alzheimer’s disease, gaps to widespread therapeutic availability and imaging remain.
These Alzheimer's tests raise many important issues that patients and their physicians should carefully consider before ...
Health and Me on MSN
Alzheimer's drug Leqembi helps over 75% of patients remain stable or improve: Real-world study
Leqembi shows promising results in over 75% of Alzheimer's patients. In the absence of a cure, the drug is a new hope for ...
"Alzheimer's disease impacts too many people, more than breast cancer and prostate cancer combined." ...
A new study on using creatine in Alzheimer's disease treatment shows promise, but experts warn more research is needed.
Advances in research have identified biomarker tests that make it possible to detect signs of neurodegenerative conditions ...
An Alzheimer’s drug could prevent dementia before symptoms show, with research suggesting it could clear toxic brain plaques ...
20hon MSN
Is the new Alzheimer's blood test available to you right now? Age restrictions and more criteria
"These blood tests should really be reserved for people who are at risk or are having early symptoms of memory issues." ...
What is sound therapy? Researchers are working to crack the link between audiovisual stimulation and Alzheimer's.
19hon MSN
Alzheimer's blood tests qualifications: Here's how doctors decide if you're an eligible candidate
"Good candidates are individuals who are identified as having cognitive impairment distinct from normal aging via abnormal ...
Reviewed by Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila Konar, ...
Just like we do for our hearts and our bodies, we need to have a multimodal approach to risk reduction of brain disease.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results